Medical Institute Achieves ALS Reversal
CBIT2 activates heat shock proteins to clear misfolded TDP-43 in ALS.
Electromyography shows complete denervation reversal in Moira Papp.
IL-10 and NfL biomarkers improve after two CBIT2 sessions.
Moira Papp no longer meets ALS criteria and stops medications.
Clinical trials for CBIT2 start in early 2026.
Alzheimer's costs $360 billion in 2024, highlighting urgent need.